- MGC Diagnostics Corporation (NASDAQ:MGCD) FQ2 results: Revenues: $8.7M (+17.6%); COGS: $4.3M (+30.3%); R&D Expense: $0.7M (+16.7%); SG&A: $3.4M (+6.2%); Operating Income: $0.2M (-33.3%); Net Income: $82K (-73.4%); EPS: $0.02 (-71.4%); Quick Assets: $5.1M (-12.1%); CF Ops: $0.3M (-78.6%).
- No guidance given.